Gayathri Tawaka
Head of Investor Relations
Replay available
Crinetics Pharmaceuticals, Inc. (CRNX) Q4 2025 Earnings Call
Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) Q4 2025 earnings conference call, held 2026-02-26. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Dr. Scott Struthers
Founder and Chief Executive Officer
Dr. Alan Krasner
Chief Endocrinologist
Toby Schoke
Chief Financial Officer
Isabel Califonos
Chief Commercial Officer
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Crinetics Pharmaceuticals, Inc..
Replay transcript excerpt
WEBVTT 00:00:01.432 -- 00:00:07.080 Welcome to Chronetics Pharmaceuticals' fourth quarter and full year 2025 financial results 00:00:07.080 -- 00:00:11.326 conference call. At this time, all participants are in listen-only mode. 00:00:11.326 -- 00:00:15.833 Following management's prepared remarks, we will hold a question and answer session. 00:00:15.833 -- 00:00:20.159 In order to ask a question, please press star then one on your telephone. 00:00:20.159 -- 00:00:24.345 I'd now like to turn the call over to Gayathri Tawaka, Head of Investor Relations. 00:00:24.345 -- 00:00:26.826 Please go ahead. 00:00:28.027 -- 00:00:32.051 Thank you, Operator. Good afternoon, everyone, and thank you for joining us to discuss 00:00:32.051 -- 00:00:35.574 the fourth quarter and four-year 2025 results. 00:00:35.574 -- 00:00:39.538 Today on the call, we have Dr. Scott Struthers, Founder and Chief Executive Officer, 00:00:39.538 -- 00:00:44.763 Dr. Alan Krasner, Chief Endocrinologist, and Toby Schoke, Chief Financial 00:00:44.763 -- 00:00:49.727 Officer. Also joining for the Q&A portion will be Isabel Califonos, Chief Commercial 00:00:49.727 -- 00:00:54.091 Officer. Please note there's a slide deck for today's presentation, which is in the Events 00:00:54.091 -- 00:00:58.435 and Presentations section of the Investors page on the Kinetics website. 00:00:58.435 -- 00:01:02.760 In addition, a press release was issued earlier today and is also available on the corporate 00:01:02.760 -- 00:01:07.165 website. As a reminder, we'll be making forward-looking statements, and I invite you 00:01:07.165 -- 00:01:12.111 to learn more about the risks and uncertainties associated with these statements as disclosed 00:01:12.111 -- 00:01:17.237 in our SEC filings. Such forward-looking statements are not ...